Gene Review:
F9 - coagulation factor IX
Mus musculus
Synonyms:
AW111646, Cf-9, Cf9, Christmas factor, Coagulation factor IX
- Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice. Kundu, R.K., Sangiorgi, F., Wu, L.Y., Kurachi, K., Anderson, W.F., Maxson, R., Gordon, E.M. Blood (1998)
- Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Hosler, B.A., LaRosa, G.J., Grippo, J.F., Gudas, L.J. Mol. Cell. Biol. (1989)
- Effect of silencer on polyomavirus DNA replication. Ariizumi, K., Takahashi, H., Nakamura, M., Ariga, H. Mol. Cell. Biol. (1989)
- Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity. Häkli, M., Lorick, K.L., Weissman, A.M., Jänne, O.A., Palvimo, J.J. FEBS Lett. (2004)
- Cloning, sequencing, and expression of the gene encoding the Clostridium stercorarium xylanase C in Escherichia coli. Ali, M.K., Fukumura, M., Sakano, K., Karita, S., Kimura, T., Sakka, K., Ohmiya, K. Biosci. Biotechnol. Biochem. (1999)
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Kay, M.A., Manno, C.S., Ragni, M.V., Larson, P.J., Couto, L.B., McClelland, A., Glader, B., Chew, A.J., Tai, S.J., Herzog, R.W., Arruda, V., Johnson, F., Scallan, C., Skarsgard, E., Flake, A.W., High, K.A. Nat. Genet. (2000)
- Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. Mingozzi, F., Liu, Y.L., Dobrzynski, E., Kaufhold, A., Liu, J.H., Wang, Y., Arruda, V.R., High, K.A., Herzog, R.W. J. Clin. Invest. (2003)
- Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. Dobrzynski, E., Fitzgerald, J.C., Cao, O., Mingozzi, F., Wang, L., Herzog, R.W. Proc. Natl. Acad. Sci. U.S.A. (2006)
- The Malmö polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F.IX polymorphisms. Graham, J.B., Lubahn, D.B., Lord, S.T., Kirshtein, J., Nilsson, I.M., Wallmark, A., Ljung, R., Frazier, L.D., Ware, J.L., Lin, S.W. Am. J. Hum. Genet. (1988)
- The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice. Cheng, Q., Zhao, Y., Lawson, W.E., Polosukhin, V.V., Johnson, J.E., Blackwell, T.S., Gailani, D. Blood (2005)
- Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells. Stoner, C.M., Gudas, L.J. Cancer Res. (1989)
- Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Fields, P.A., Arruda, V.R., Armstrong, E., Chu, K., Mingozzi, F., Hagstrom, J.N., Herzog, R.W., High, K.A. Mol. Ther. (2001)
- Mapping of FMR1, the gene implicated in fragile X-linked mental retardation, on the mouse X chromosome. Laval, S.H., Blair, H.J., Hirst, M.C., Davies, K.E., Boyd, Y. Genomics (1992)
- The properdin structural locus (Pfc) lies close to the locus for tissue inhibitor of metallothionine proteases (Timp) on the mouse X chromosome. Laval, S.H., Chen, Z.Y., Boyd, Y. Genomics (1991)
- Localization of the mouse Mcf-2 (Dbl) protooncogene within a conserved linkage group on the mouse X chromosome. Grant, S.G., Mattei, M.G., Galland, F., Stephenson, D.A., Keitz, B.T., Birnbaum, D., Chapman, V.M. Cytogenet. Cell Genet. (1990)
- Creation of a mouse expressing defective human factor IX. Jin, D.Y., Zhang, T.P., Gui, T., Stafford, D.W., Monahan, P.E. Blood (2004)
- Overexpression of uvomorulin in a compaction-negative F9 mutant cell line. Calogero, A., Samuels, M., Darland, T., Edwards, S.A., Kemler, R., Adamson, E.D. Dev. Biol. (1991)
- Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Nathwani, A.C., Davidoff, A., Hanawa, H., Zhou, J.F., Vanin, E.F., Nienhuis, A.W. Blood (2001)
- Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Gordon, E.M., Skotzko, M., Kundu, R.K., Han, B., Andrades, J., Nimni, M., Anderson, W.F., Hall, F.L. Hum. Gene Ther. (1997)
- Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. Shayakhmetov, D.M., Gaggar, A., Ni, S., Li, Z.Y., Lieber, A. J. Virol. (2005)
- Cloning and sequencing of a full-length cDNA of mouse N-acetylglucosamine (beta 1-4)galactosyltransferase. Nakazawa, K., Ando, T., Kimura, T., Narimatsu, H. J. Biochem. (1988)
- Genetic mapping of the mouse X chromosome in the region homologous to human Xq27-Xq28. Herman, G.E., Faust, C.J., Darlison, M.G., Barnard, E.A. Genomics (1991)
- Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells. Telford, N.A., Hogan, A., Franz, C.R., Schultz, G.A. Mol. Reprod. Dev. (1990)
- Strand-specific LINE-1 transcription in mouse F9 cells originates from the youngest phylogenetic subgroup of LINE-1 elements. Schichman, S.A., Severynse, D.M., Edgell, M.H., Hutchison, C.A. J. Mol. Biol. (1992)
- A coagulation factor IX-deficient mouse model for human hemophilia B. Lin, H.F., Maeda, N., Smithies, O., Straight, D.L., Stafford, D.W. Blood (1997)
- Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Hagstrom, J.N., Couto, L.B., Scallan, C., Burton, M., McCleland, M.L., Fields, P.A., Arruda, V.R., Herzog, R.W., High, K.A. Blood (2000)
- Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector. Liu, Y.L., Mingozzi, F., Rodriguéz-Colôn, S.M., Joseph, S., Dobrzynski, E., Suzuki, T., High, K.A., Herzog, R.W. Hum. Gene Ther. (2004)